# Surgical Stabilizer Assisted RVC With rtPA for CRVO

> **NCT03417401** · PHASE1 · WITHDRAWN · sponsor: **Universitaire Ziekenhuizen KU Leuven**

## Conditions studied

- Central Retinal Vein Occlusion

## Interventions

- **PROCEDURE:** Vitrectomy with retinal vein cannulation and intravenous rtPA (Actilyse) infusion up to 1mg.
- **DRUG:** Intravenous Infusion

## Key facts

- **NCT ID:** NCT03417401
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10-16
- **Primary completion:** 2021-12-10
- **Final completion:** 2021-12-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** organizationally not yet possible
- **Last updated:** 2023-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03417401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03417401, "Surgical Stabilizer Assisted RVC With rtPA for CRVO". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03417401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*